Metabolic Signatures of Type 2 Diabetes Mellitus and Hypertension in COVID-19 Patients With Different Disease Severity

Abstract

Introduction: Increased COVID-19 disease severity is higher among patients with type 2 diabetes mellitus and hypertension. However, the metabolic pathways underlying this association are not fully characterized. This study aims to identify the metabolic signature associated with increased COVID-19 severity in patients with diabetes mellitus and hypertension.Methods: One hundred and fifteen COVID-19 patients were divided based on disease severity, diabetes status, and hypertension status. Targeted metabolomics of serum samples from all patients was performed using tandem mass spectrometry followed by multivariate and univariate models.Results: Reduced levels of various triacylglycerols were observed with increased disease severity in the diabetic patients, including those containing palmitic (C16:0), docosapentaenoic (C22:5, DPA), and docosahexaenoic (C22:6, DHA) acids (FDR < 0.01). Functional enrichment analysis revealed triacylglycerols as the pathway exhibiting the most significant changes in severe COVID-19 in diabetic patients (FDR = 7.1 × 10−27). Similarly, reduced levels of various triacylglycerols were also observed in hypertensive patients corresponding with increased disease severity, including those containing palmitic, oleic (C18:1), and docosahexaenoic acids. Functional enrichment analysis revealed long-chain polyunsaturated fatty acids (n-3 and n-6) as the pathway exhibiting the most significant changes with increased disease severity in hypertensive patients (FDR = 0.07).Conclusions: Reduced levels of triacylglycerols containing specific long-chain unsaturated, monounsaturated, and polyunsaturated fatty acids are associated with increased COVID-19 severity in diabetic and hypertensive patients, offering potential novel diagnostic and therapeutic targets.

Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: A bidirectional Mendelian randomization study

“…It has rapidly become a global epidemic and a serious health threat (1). Currently, several studies have shown that some susceptible populations include type 2 diabetes, obesity, hypertension, and other metabolic diseases (2)(3)(4)(5). However, thyroid disease is not covered in the report.…”

The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection

“…Currently, the impact of BCG vaccinations seems to be largely hypothetical or non-specific in decreasing the severity of COVID-19 infection. Our previous study suggested a difference in the metabolic signature of Type 2 diabetic patients with COVID-19 infection compared to non-diabetic population (20). In general, diabetic patients are at a greater risk of disease progression when infected with SARS-CoV-2.…”

Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice

“…Meanwhile, individual with severe COVID-19 show elevated plasma triglycerides (TGs), ceramides (Cer), and phosphatidylethanolamines (PEs), alongside a reduction in PCs and Lysophosphatidylcholines (LPCs), particularly LPC 20:1 [ 22 ]. Furthermore, the severity of COVID-19 in diabetic and hypertensive patients has been linked to long-chain polyunsaturated fatty acids (n3 and n6) [ 23 ]. More notably, research recognizes that certain ACE2 variants increase the binding affinity to the spike protein therefore leading to more severe infections [ 24 ].…”